Hence, CDKN2A homozygous deletion is now considered a CNS WHO grade 4 diagnostic marker in IDH-mutant astrocytomas, even in the absence of necrosis and/or microvascular proliferation on histology [1]. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).